Home / Healthcare / Medical Device / U.S. Biosimilars Market

U.S. Biosimilars Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, and Others), By Disease Indication (Cancer, Autoimmune Diseases {Arthritis, Psoriasis, Neutropenia, and Others}, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Report Format: PDF | Latest Update: Jul, 2023 | Published Date: May, 2022 | Report ID: FBI100990 | Status : Published
  • 2021
  • 105
  • PRICE
  • $ 2850
    $ 3850
    $ 4850
    Buy Now

Healthcare Clients